Announcement of new article publication Cardiovascular innovations and applications journal. Thrombosis, the process by which blood clots form within blood vessels, is an important protective mechanism to avoid excessive blood loss when a person is exposed to trauma. The body has both clot-suppressing and clot-clearing systems that interact in a balanced manner. Thrombosis occurs when these mechanisms become unbalanced and excessive blood clots form and occlude the lumen.

Thrombosis is currently the leading cause of death from human diseases and is one of the most common events causing many cardiovascular diseases. Antithrombotic drugs are an integral part of the pharmacological treatment plan and are currently recommended intervention strategies for thrombotic complications in patients with thrombosis. Despite significant advances in these treatments, there is a high risk associated with thrombosis and bleeding due to the complex interactions between patient comorbidities, drug combinations, multifaceted dose adjustments, and the care environment. still remains.

Establishing an optimal treatment plan for patients with thrombosis requires a detailed evaluation of the effects of bleeding and thrombosis. In this study, we retrospectively evaluated methods to assess hemorrhage/ischemia risk in thrombosis and the individual use of these methods.